SenesTech to Report Third Quarter 2026 Financial Results on Tuesday, November 10, 2026
Senestech Inc SNES
$1.11
βΌ -2.63%
($-0.03)
⬇️ Below Yest. Low
🎈 Low Float
📅 Earnings This Week
Open
$1.14
Prev Close
$1.14
Day Range
$1.08 β $1.16
52W Range
$0.55 β $3.61
Market Cap
$6.18M
Beta
0.11
EPS (TTM)
$-1.36
π Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2016-12-08 |
| Shares Out. | 5,420,000 |
| Website | senestech.com β |
| Phone | 19287794143 |
| Employees | 24 |
| Revenue | $770,000 |
| Gross Profit | $567,000 |
| Net Income | -$1.8M |
| Free Cash Flow | -$6.7M |
| Total Assets | $9.4M |
| Total Liabilities | $3.4M |
| Equity | $6.1M |
About Senestech Inc
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company has developed and are commercializing products for managing animal pest populations through fertility control and population management strategies. Its current products focus on rat and mouse populations, and are known as: ContraPest, Evolve Rat, and Evolve Mouse.
Senestech Inc is a publicly traded company under the ticker symbol SNES on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
π Analyst Ratings
7 analysts (2026-11-01)
π° Latest News for SNES
SenesTech Expands E-Commerce Reach Through Walmart Fulfillment Services
SenesTech Expands Evolve Product Distribution Through Walmart Fulfillment Services
SNES: Brand Strategist Sandstrom Partners Engaged as SNES Record of Successful Deployments Grows
SenesTech: Sandstrom Partners Hired As Strategic Advisor on Marketing and Branding
Sandstrom Partners Hired As Strategic Advisor on Marketing and Branding
